Considering that resveratrol was previously shown to inhibit purified chicken FASN with an IC50 of 11.1 μg/mL in vitro, we further explored whether resveratrol modulates FASN expression and intracellular activity in breast cancer cells. This evidence concerns the gene FASN and breast carcinoma.